Join Veristat and more than 300 local attendees to discuss and evaluate the best practices that have evolved in shortening time to market at the 5th Annual MassBio CRO/CMO Symposium.
Join Veristat at the ASH Annual Meeting & Exposition, the world’s largest hematology conference geared towards clinicians, researchers and scientists who are looking to further the understanding, diagnosis, treatment, and prevention of blood disorders. Today, the ASH annual meeting attracts more than 20,000 attendees from all over the world.
Veristat to present at Harvard Drug Development Boot Camp
November 14, 2016
Come join Veristat and a panel of drug development experts for a two day intensive boot camp targeted for executive level leaders who make drug development decisions on a daily basis.
John Balser to Moderate Forum on Adaptive Designs in Clinical Trials
November 2, 2016
Come join the conversation being moderated by John Balser, PhD, President of Veristat. Bring your challenging questions and be prepared to share your experiences with adaptive designs.
Have you ever wondered how biotech and pharma companies make informed decisions as to whether an adaptive design would be useful in their development programs?